1. Molendijk M, Hazes JM, Lubberts E. From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis? RMD Open 2018;4:e000256. [DOI:10.1136/rmdopen-2016-000256]

2. Tenstad HB, Nilsson AC, Dellgren CD, Lindegaard HM, Rubin KH, Lillevang ST. Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis. Scand J Rheumatol 2020;49:18-20. [DOI:10.1080/03009742.2019.1609079]

3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8. [DOI:10.1136/ard.2010.138461]

4. Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F, et al. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis. Intern Med 2019;58:1703-12. [DOI:10.2169/internalmedicine.2226-18]

5. Suda T. Up-to-date information on rheumatoid arthritis-associated interstitial lung disease. Clin Med Insights Circ Respir Pulm Med 2015;9:155-62. [DOI:10.4137/CCRPM.S23289]

6. Minichiello E, Semerano L, Boissier MC. Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review. Joint Bone Spine 2016;83:625-30. [DOI:10.1016/j.jbspin.2016.07.007]

7. Wilczynska MM, Condliffe AM, McKeon DJ. Coexistence of bronchiectasis and rheumatoid arthritis: revisited. Respir Care 2013;58:694-701. [DOI:10.4187/respcare.01857]

8. Salaffi F, Carotti M, Di Carlo M, Tardella M, Giovagnoni A. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore) 2019;98:e17088. [DOI:10.1097/MD.0000000000017088]

9. Atzeni F, Talotta R, Masala IF, Bongiovanni S, Boccassini L, Sarzi-Puttini P. Biomarkers in rheumatoid arthritis. Isr Med Assoc J 2017;19:512-6.

10. Humphreys JH, van Nies JA, Chipping J, Marshall T, van der Helm-van Mil AH, Symmons DP, et al. Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts. Arthritis Res Ther 2014;16:483. [DOI:10.1186/s13075-014-0483-3]

11. Azadi Ghatar S, Meshkini A, Roknoldin Eftekhari A, Mostafavi E, Ahadnejad Reveshty M, Maleki P. Modelling the spatial association of lung cancer with built environmental factors in neighborhoods of Tehran Metropolitan. Hum Geogr J 2020;52:1153-76.

12. Murgia N, Brisman J, Claesson A, Muzi G, Olin AC, Torén K. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulm Med 2014;14:49. [DOI:10.1186/1471-2466-14-49]

13. Chen RX, Zhao LD, Xiao XY, Song L, Du HY, Xu ZJ, et al. Distinctive clinical characteristics and outcome of ILD-Onset rheumatoid arthritis and ACPA-positive ILD: A longitudinal cohort of 282 cases. Clin Rev Allergy Immunol 2021;60:46-54. [DOI:10.1007/s12016-020-08819-0]

14. Zhu J, Zhou Y, Chen X, Li J. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol 2014;41:1282-9. [DOI:10.3899/jrheum.131341]

15. Friedlander HM, Ford JA, Zaccardelli A, Terrio AV, Cho MH, Sparks JA. Obstructive lung diseases and risk of rheumatoid arthritis. Expert Rev Clin Immunol 2020;16:37-50. [DOI:10.1080/1744666X.2019.1698293]

16. Natalini JG, Baker JF, Singh N, Mahajan TD, Roul P, Thiele GM, et al. Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S. Veterans. Ann Am Thorac Soc 2021;18:598-605. [DOI:10.1513/AnnalsATS.202006-590OC]

17. Brito Y, Glassberg MK, Ascherman DP. Rheumatoid arthritis-Associated interstitial lung disease: Current concepts. Curr Rheumatol Rep 2017;19:79. [DOI:10.1007/s11926-017-0701-5]

18. Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012;7:e35296. [DOI:10.1371/journal.pone.0035296]

19. Holers VM, Demoruelle MK, Kuhn KA, Buckner JH, Robinson WH, Okamoto Y, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol 2018;14:542-57. [DOI:10.1038/s41584-018-0070-0]

20. Emad Y, Ragab Y, Hammam N, El-Shaarawy N, Ibrahim O, Gamal RM, et al. Autoantibodies to extractable nuclear antigens (ENAs) pattern in rheumatoid arthritis patients: Relevance and clinical implications. Reumatol Clin (Engl Ed) 2021;17:250-57. [In English, Spanish] [DOI:10.1016/j.reumae.2019.10.005]

21. Lv H, Liu J, Pan Q, Cai R, Zhang J. Clinical retrospective analysis of interstitial lung disease patients associated with pulmonary hypertension. Med Sci Monit 2019;25:7763-9. [DOI:10.12659/MSM.916585]

22. Ledda C, Caltabiano R, Loreto C, Cina D, Senia P, Musumeci A, et al. Prevalence of anti-nuclear autoantibodies in subjects exposed to natural asbestiform fibers: a cross-sectional study. J Immunotoxicol 2018;15:24-8. [DOI:10.1080/1547691X.2017.1415398]

23. Jee AS, Adelstein S, Bleasel J, Keir GJ, Nguyen M, Sahhar J, et al. Role of autoantibodies in the diagnosis of connective-Tissue disease ILD (CTD-ILD) and interstitial pneumonia with autoimmune features (IPAF). J Clin Med 2017;6:51. [DOI:10.3390/jcm6050051]